AI imaging software developer Astute Imaging is entering into an agreement with Nectero Medical, the developer of the Nectero Endovascular Aneurysm Stabilization Treatment (EAST) System.
Under this partnership, Nectero Medical will use Astute Imaging's technologies in its phase II/III clinical trial for the treatment of small- to mid-sized abdominal aortic aneurysms. The two previously worked together on Nectero's phase I clinical trial in this area.
